In this Viewpoint, Ehab Hanna, MD, president of the American Head and Neck Society, gives the 2019 annual meeting address.
This Viewpoint describes quality of life and other factors that should be considered when elderly patients make cancer treatment decisions.
This retrospective cohort study assesses the performance of the traditional pathologic risk stratification system for surgically resected human papillomavirus–associated oropharyngeal squamous cell carcinoma and proposes an alternate composite risk stratification system.
This cohort study describes a model using machine learning to help predict 5-year overall survival among patients with oral squamous cell carcinoma (OSCC) and compares this model with a prediction model created from the TNM (Tumor, Node, Metastasis) clinical and pathologic stage.
This study uses Veterans Affairs Corporate Data Warehouse data to examine whether there is an association between prior hematologic malignant tumor and risk of head and neck cancer and assesses the overall survival among these patients.
This cohort study evaluates the association of the addition of adult patients’ functional performance to other important preoperative clinical characteristics with 30-day and 90-day hospital readmissions and overall survival after surgical treatment of head and neck cancer.
This case series study analyzes intraoperative facial nerve monitoring data from adult patients who had a parotidectomy operation and identifies the monitoring parameters associated with postoperative nerve weakness.
This cohort study of 131 779 patients with head and neck cancer examines the association of the Patient Protection and Affordable Care Act with insurance status across socioeconomic and demographic subpopulations.
This cohort study examines factors associated with 30-day postoperative complications, 90-day mortality, and 90-day functional decline and creates a preoperative risk stratification system for elderly patients undergoing head and neck ablation and reconstruction.
This cohort study uses the SEER-Medicare outcomes and claims database to evaluate the quality, outcomes, and costs associated with radiation therapy with or without cisplatin or cetuximab for older adults with stage III to IVB head and neck cancer.
This cohort study assesses whether age and frailty are associated with preoperative and/or worsening postoperative depression and postoperative decision regret in patients undergoing major head and neck surgery and identifies additional factors associated with depression and decision regret.
Create a personal account or sign in to: